NASDAQ: MYGN
Myriad Genetics Inc Stock Ownership - Who owns Myriad Genetics?

Insider buying vs selling

Have Myriad Genetics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Benjamin Richard WheelerCFO2026-09-212,555$4.01
$10.25kSell
Jennifer Lynne FoxCLO2026-09-034,398$3.23
$14.21kSell
Benjamin Richard WheelerCFO2026-08-168,761$3.03
$26.55kSell
Samraat S. RahaPresident and CEO2026-06-113,542$3.94
$13.94kBuy
Brian J. DonnellyChief Commerical Officer2026-06-115,000$3.94
$19.68kBuy
Rashmi KumarDirector2026-06-0815,000$4.46
$66.84kSell
Paul BisaroDirector2026-05-147,500$3.69
$27.64kBuy
Brian J. DonnellyChief Commerical Officer2026-05-0155,975$4.80
$268.68kSell
Dale MuzzeyChief Scientific Officer2026-04-14946$4.91
$4.64kSell
Mark VerrattiChief Operating Officer2026-04-141,069$4.91
$5.25kSell

1 of 5

MYGN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when MYGN insiders and whales buy or sell their stock.

MYGN Shareholders

What type of owners hold Myriad Genetics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Samraat S. Raha1.12%1,068,083$4.85MInsider
Paul J. Diaz0.93%891,844$4.05MInsider
Mark H. Skolnick0.80%764,724$3.47MInsider
Mark Verratti0.66%629,646$2.86MInsider
Brian J. Donnelly0.60%573,363$2.60MInsider
Mark Christopher Capone0.55%522,216$2.37MInsider
S. Louise Phanstiel0.39%374,771$1.70MInsider
Dale Muzzey0.34%326,310$1.48MInsider
Jennifer Lynne Fox0.32%305,964$1.39MInsider
Richard Bryan Riggsbee0.31%291,812$1.32MInsider

1 of 3

MYGN vs Diagnostic & Research Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MYGN0.09%11.78%Net SellingNet Selling
BDSX0.01%99.99%Net BuyingNet Buying
FLGT0.06%49.26%Net SellingNet Selling
ACRS0.08%53.53%Net SellingNet Selling
XGN0.03%46.67%Net SellingNet Selling

Myriad Genetics Stock Ownership FAQ

Who owns Myriad Genetics?

Myriad Genetics (NASDAQ: MYGN) is owned by 0.09% institutional shareholders, 11.78% Myriad Genetics insiders, and 88.12% retail investors. Samraat S. Raha is the largest individual Myriad Genetics shareholder, owning 1.07M shares representing 1.12% of the company. Samraat S. Raha's Myriad Genetics shares are currently valued at $4.85M.

If you're new to stock investing, here's how to buy Myriad Genetics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.